Background Small amounts of nutrients given as a ‘preload’ can reduce post-meal hyperglycaemic peaks in type 2 diabetes (T2D) patients by activating a number of mechanisms involved in glucose homoeostasis. This study was undertaken to ascertain whether this positive effect extends to the late absorptive phase and to identify the main mechanisms involved. Material and methods Eight well-controlled T2D patients, aged 40–70 years, were randomized to consume a ‘preload’ of either water or non-glucidic nutrients (50 g of Parmesan cheese, one boiled egg) 30 min before a 300-min oral glucose tolerance test. Results After the nutrient preload, significant reductions were observed in peak glucose (−49%; P < 0.02), total plasma glucose (iAUC: −28%; P < 0.03), exogenous glucose (iAUC: −30%; P < 0.03) and insulin clearance (−28%; P < 0.04), with enhancement of insulin secretion (iAUC: +22%; P < 0.003). These effects were associated with higher plasma levels of GLP-1 (iAUC: +463%; P < 0.002), GIP (iAUC: +152%; P < 0.0003) and glucagon (iAUC: +144%; P < 0.0002). Conclusion In T2D patients, a protein and lipid preload improves glucose tolerance throughout the whole post-absorptive phase mainly by reducing the appearance of oral glucose, and improving both beta-cell function and insulin bioavailability.

Sustained effects of a protein and lipid preload on glucose tolerance in type 2 diabetes patients

Tricò, D.
;
BALDI, Sara;
2016-01-01

Abstract

Background Small amounts of nutrients given as a ‘preload’ can reduce post-meal hyperglycaemic peaks in type 2 diabetes (T2D) patients by activating a number of mechanisms involved in glucose homoeostasis. This study was undertaken to ascertain whether this positive effect extends to the late absorptive phase and to identify the main mechanisms involved. Material and methods Eight well-controlled T2D patients, aged 40–70 years, were randomized to consume a ‘preload’ of either water or non-glucidic nutrients (50 g of Parmesan cheese, one boiled egg) 30 min before a 300-min oral glucose tolerance test. Results After the nutrient preload, significant reductions were observed in peak glucose (−49%; P < 0.02), total plasma glucose (iAUC: −28%; P < 0.03), exogenous glucose (iAUC: −30%; P < 0.03) and insulin clearance (−28%; P < 0.04), with enhancement of insulin secretion (iAUC: +22%; P < 0.003). These effects were associated with higher plasma levels of GLP-1 (iAUC: +463%; P < 0.002), GIP (iAUC: +152%; P < 0.0003) and glucagon (iAUC: +144%; P < 0.0002). Conclusion In T2D patients, a protein and lipid preload improves glucose tolerance throughout the whole post-absorptive phase mainly by reducing the appearance of oral glucose, and improving both beta-cell function and insulin bioavailability.
2016
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11382/524794
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
social impact